Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 20, 2026
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial.
Journal: JAMA oncology
Published: December 12, 2024
Breast Cancer Polygenic Risk Score Validation and Effects of Variable Imputation.
Journal: Cancers
Published: February 29, 2024
Case report: 16-yr life history and genomic evolution of an ER+ HER2- breast cancer.
Journal: Cold Spring Harbor molecular case studies
Published: June 01, 2020
Utilizing Tumor and Plasma Liquid Biopsy in Treatment Decision Making for an Estrogen Receptor-Positive Advanced Breast Cancer Patient.
Journal: Cureus
Published: September 01, 2017
Down's Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship.
Journal: International journal of molecular sciences
Published: April 17, 2017
Identifying biomarkers to select patients with early breast cancer suitable for extended adjuvant endocrine therapy.
Journal: Current opinion in oncology
Published: September 09, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026